PO No :PO3758436865-720

Name : Mr.MOHAMMED AZLAN Client Name : TATA 1MG BANGALORE

Age/Gender : 8/Male Referred By : Dr.
Patient ID : MGB1243922 Collection Date : 05/Jun/2025 08:19AM
Barcode ID/Order ID : D19965809 / 13064439 Report Date : 05/Jun/2025 04:07PM
Sample Type : EDTA Report Status : Final Report

HAEMATOLOGY
SUPER EMPLOYEE HEALTH CHECK-UP
Test Name Result Unit Bio. Ref. Interval Method

Complete Blood Count

Hemoglobin 12 g/dL 11.5 - 15.5 Spectrophotometry
(Cyanide-free)
RBC 4.81 mili/cu.mm 4.0 - 5.2 Impedence
HCT 36.4 % 35 - 45 Calculated
MCV 75.8 fL 77 - 95 Calculated
MCH 24.9 pg 25 - 33 Calculated
MCHC 32.8 g/dL 31 - 37 Calculated
RDW-SD 33.80 fL 39-46 Calculated
RDW-CV 12.8 % 11.5-14 Calculated
Total Leucocyte Count 10.29 10^3/µL 4.7 - 12.3 Impedance
Differential Leucocyte Count
Neutrophils 62.3 % 32-71 DHSS/Microscopy
Lymphocytes 27.5 % 20-59 DHSS/Microscopy
Monocytes 9.2 % 2-10 DHSS/Microscopy
Eosinophils 1 % 0-8 DHSS/Microscopy
Basophils 0 % 0-1 Impedance/Microscopy
Absolute Leucocyte Count
Absolute Neutrophil Count 6.41 10^3/µL 1.8 - 7.7 Calculated
Absolute Lymphocyte Count 2.83 10^3/µL 1.6 - 5.1 Calculated
Absolute Monocyte Count 0.95 10^3/µL 0.1 - 1 Calculated
Absolute Eosinophil Count 0.1 10^3/µL 0 - 0.6 Calculated
Absolute Basophil Count 0 10^3/µL 0 - 0.1 Calculated
Platelet Count 394 10^3/µL 170 - 450 Impedance/Microscopy
MPV 7.2 fL 6.5 - 12 Calculated
PDW 10.9 fL 9-17 Calculated

Comment:
As per the recommendation of International council for Standardization in Hematology, the differential leucocyte counts are
additionally being reported as absolute numbers of each cell in per unit volume of blood.
DHSS : Double Hydrodynamic Sequential System Flowcytometry
Calculated parameters are either derived from Impedence measure, RBC pulse measurement, RBC/platelet histograms or

This test has been performed at

TATA 1MG BANGALORE
Address: No 607, Ground, 1st & 2nd Floor, 80
Feet Road, 6th Block, Koramangala,
Bengaluru, 560095

Page 1 of 14
 PO No :PO3758436865-720

Name : Mr.MOHAMMED AZLAN Client Name : TATA 1MG BANGALORE

Age/Gender : 8/Male Referred By : Dr.
Patient ID : MGB1243922 Collection Date : 05/Jun/2025 08:19AM
Barcode ID/Order ID : D19965809 / 13064439 Report Date : 05/Jun/2025 04:07PM
Sample Type : EDTA Report Status : Final Report

HAEMATOLOGY
SUPER EMPLOYEE HEALTH CHECK-UP
Test Name Result Unit Bio. Ref. Interval Method
formula derived.

Erythrocyte Sedimentation Rate

Erythrocyte Sedimentation Rate 31 mm/hr 0-20 Modified Westergren at
18C

Comment:

ESR provides an index of progress of the disease and is widely used as an indicator of inflammation, infection, trauma, or
malignant diseases. Changes are more significant than a single abnormal test
It is specifically indicated to monitor the course or response to the treatment of diseases like rheumatoid arthritis,
tuberculosis bacterial endocarditis ,acute rheumatic fever ,Hodgkins disease,temporal arthritis , and systemic lupus
erythematosis; and to diagnose and monitor giant cell arteritis and polymyalgia rheumatica.
An elevated ESR may also be associated with many other conditions, including autoimmune disease, anemia,
infection,malignancy,pregnancy, multiple myeloma, menstruation, and hypothyroidism.
Although a normal ESR cannot be taken to exclude the presence of organic disease, its rate is dependent on various
physiologic and pathologic factors.
The most important component influencing ESR is the composition of plasma. High level of C-Reactive Protein, fibrinogen,
haptoglobin, alpha-1antitrypsin, ceruloplasmin and immunoglobulins causes the elevation of Erythrocyte Sedimentation
Rate.
Drugs that may cause increase ESR levels include: dextran, methyldopa, oral contraceptives, penicillamine, procainamide,
theophylline, and Vitamin A. Drugs that may cause decrease levels include: aspirin, cortisone, and quinine

This test has been performed at

TATA 1MG BANGALORE
Address: No 607, Ground, 1st & 2nd Floor, 80
Feet Road, 6th Block, Koramangala,
Bengaluru, 560095

Page 2 of 14
 PO No :PO3758436865-720

Name : Mr.MOHAMMED AZLAN Client Name : TATA 1MG BANGALORE

Age/Gender : 8/Male Referred By : Dr.
Patient ID : MGB1243922 Collection Date : 05/Jun/2025 08:19AM
Barcode ID/Order ID : D19965809 / 13064439 Report Date : 05/Jun/2025 03:01PM
Sample Type : WHOLE BLOOD-EDTA Report Status : Final Report

HAEMATOLOGY
SUPER EMPLOYEE HEALTH CHECK-UP
Test Name Result Unit Bio. Ref. Interval Method

HbA1c (Glycosylated Hemoglobin)

Glycosylated Hemoglobin (HbA1c) 5.9 % 4-5.6 HPLC (NGSP certified)
Estimated average glucose (eAG) 122.63 mg/dL Calculated

Comment:
Interpretation: HbA1c%

≤5.6 Normal
5.7-6.4 At Risk For Diabetes
≥6.5 Diabetes

Adapted from American Diabetes Association.

Comments:
A 3 to 6 monthly monitoring is recommended in diabetics. People with diabetes should get the test done more often if their blood
sugar stays too high or if their healthcare provider makes any change in the treatment plan. HbA1c concentration represent the
integrated values for blood glucose over the preceding 8-12 weeks and is not affected by daily glucose fluctuation, exercise &
recent food intake.
Please note, Glycemic goal should be individualized based on duration of diabetes, age/life expectancy, comorbid conditions,
known CVD or advanced microvascular complications, hypoglycemia unawareness, and individual patient considerations.

Factors thatinterfere with HbA1c Measurement:Hemoglobin variants, elevated fetal hemoglobin (HbF) and chemically modified
derivatives of hemoglobin (e.g. carbamylated Hb in patients with renal failure) can affect the accuracy of HbA1c measurements.

Factors thataffect interpretation ofHbA1c Measurement:Any condition that shortens erythrocyte survival or decrease mean
erythrocyte age (e. g., recovery from acute blood loss, hemolytic anemia, HbSS, HbCC, and HbSC) will falsely lower HbA1c test
results regardless of the assay method used. Iron deficiency anemia is associated with higher HbA1c.

Note: Presence of Hemoglobin variants and/or conditions that affect red cell turnover must be considered, particularly when the
HbA1c result does not correlate with the patient's blood glucose levels.

• HPLC - High performance liquid chromatography

This test has been performed at

TATA 1MG BANGALORE
Address: No 607, Ground, 1st & 2nd Floor, 80
Feet Road, 6th Block, Koramangala,
Bengaluru, 560095

Page 3 of 14
This test has been performed at
TATA 1MG BANGALORE
Address: No 607, Ground, 1st & 2nd Floor, 80
Feet Road, 6th Block, Koramangala,
Bengaluru, 560095

Page 4 of 14
PO No :PO3758436865-720

Name : Mr.MOHAMMED AZLAN Client Name : TATA 1MG BANGALORE

Age/Gender : 8/Male Referred By : Dr.
Patient ID : MGB1243922 Collection Date : 05/Jun/2025 08:19AM
Barcode ID/Order ID : D19965811 / 13064439 Report Date : 05/Jun/2025 05:40PM
Sample Type : Serum Report Status : Final Report

BIOCHEMISTRY
SUPER EMPLOYEE HEALTH CHECK-UP
Test Name Result Unit Bio. Ref. Interval Method

Lipid Profile
Cholesterol - Total 149 mg/dL Desirable <170 Enzymatic
Borderline high 170–199
High >=200
Triglycerides 103 mg/dL Normal: <75, Glycerol Phosphate
Borderline: 75 - 99, Oxidase
High:>=100
Cholesterol - HDL 30 mg/dL Low HDL: <40 mg/dL Accelerator Selective
Borderline Low: 40-45 Detergent
mg/dL
Acceptable: >45 mg/dL
Cholesterol - LDL 98 mg/dl Acceptable: <110 mg/dLCalculated
Borderline High: 110-129
mg/dL
High: > or =130 mg/dL
Cholesterol- VLDL 21 mg/dl <15 Calculated
Cholesterol : HDL Cholesterol 5.0 Ratio Desirable : 3.5-4.5 Calculated
High Risk : >5
LDL : HDL Cholesterol 3.28 Ratio Desirable : 2.5-3.0 Calculated
High risk : >3.5
Non HDL Cholesterol 119 mg/dL Acceptable: <120 mg/dLCalculated
Borderline High: 120-144
mg/dL
High: >=145 mg/dL
HDL : LDL Ratio 0.30 Ratio >0.3 Calculated

Comment:
• Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial
samples 1 week apart may be tested.
• Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe
with high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.
•Total cholesterolis the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.
•LDL Cholesterol (LDL-C) or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or
stroke and is the primary target for reducing risk for cardiovascular disease.
•High-density lipoprotein (HDL)or “good” cholesterol can lower risk of heart disease and stroke.

This test has been performed at

TATA 1MG BANGALORE
Address: No 607, Ground, 1st & 2nd Floor, 80
Feet Road, 6th Block, Koramangala,
Bengaluru, 560095

Page 5 of 14
This test has been performed at
TATA 1MG BANGALORE
Address: No 607, Ground, 1st & 2nd Floor, 80
Feet Road, 6th Block, Koramangala,
Bengaluru, 560095

Page 6 of 14
PO No :PO3758436865-720

Name : Mr.MOHAMMED AZLAN Client Name : TATA 1MG BANGALORE

Age/Gender : 8/Male Referred By : Dr.
Patient ID : MGB1243922 Collection Date : 05/Jun/2025 08:19AM
Barcode ID/Order ID : D19965811 / 13064439 Report Date : 05/Jun/2025 05:40PM
Sample Type : Serum Report Status : Final Report

BIOCHEMISTRY
SUPER EMPLOYEE HEALTH CHECK-UP
Test Name Result Unit Bio. Ref. Interval Method
Bilirubin-Total 0.40 mg/dL 0.3-1.2 Diazonium Salt
Bilirubin-Direct 0.14 mg/dL 0.05-0.20 Diazo
Bilirubin-Indirect 0.26 mg/dL 0.2-0.8 Calculated
Protein, Total 7.60 g/dL 6.0-8.0 Biuret
Albumin 4.40 g/dL 3.8-5.4 Bromocresol Green
Globulin 3.2 g/dL 2.1 - 3.2 Calculated
A/G Ratio 1.38 Ratio 1.27 - 1.99 Calculated
Aspartate Transaminase (SGOT) 24 U/L 18-36 NADH w/o P-5’-P
SGPT (Alanine Transaminase) 11 U/L 9-25 NADH w/o P-5’-P
SGOT/SGPT 2.18 Ratio Calculated
Alkaline Phosphatase 188 U/L <500 Para-Nitrophenyl
Phosphate
Gamma Glutamyltransferase (GGT) 12 U/L 12-55 L-gamma-glutamyl-3-
Carboxy-4-Nitroanilide

Comment:

Raised ALT and AST indicate hepatocellular damage (e.g. viral or drugs etc). ALT is more liver-specific while AST is also
found in heart, skeletal muscle, and kidney. Mild elevation (less than twice normal) often resolves on its own. Fatty liver
disease (especially with metabolic syndrome) is a common cause in asymptomatic cases. Certain drugs (paracetamol,
statins), herbal supplements, energy drinks, and antibiotics may also affect liver function.
SGOT/SGPT Ratio: Typically <1 in healthy individuals (vary between 0.7-1.4; higher in women than men). High SGPT (ratio
<1) seen in acute or chronic hepatitis, autoimmune disorders, medications, toxins while ratio >1 indicates alcoholic
hepatitis, cirrhosis, metastasis or non-hepatic issues (hemolytic diseases, CVS disorders).
Elevated Alkaline Phosphatase and GGT: Suggest cholestatic diseases (e.g. bile duct obstruction, primary biliary
cirrhosis etc.) and can also be due to bone disease, pregnancy, chronic renal failure, malignancy, and congestive heart
failure.
High Bilirubin: Indicates jaundice due to increased RBC breakdown, liver damage (e.g., infections, toxins), or cholestasis
(e.g., gallstones, tumors ).
High Protein Levels: Seen in dehydration (e.g., severe vomiting, diarrhea) or increased production (e.g., inflammation,
hematopoietic neoplasms). Low protein and albumin: Result from impaired synthesis (liver disease), decreased intake,
tissue damage, malabsorption, or increased renal excretion.

*Please note the change in BRI.

This test has been performed at

TATA 1MG BANGALORE
Address: No 607, Ground, 1st & 2nd Floor, 80
Feet Road, 6th Block, Koramangala,
Bengaluru, 560095

Page 7 of 14
PO No :PO3758436865-720

Name : Mr.MOHAMMED AZLAN Client Name : TATA 1MG BANGALORE

Age/Gender : 8/Male Referred By : Dr.
Patient ID : MGB1243922 Collection Date : 05/Jun/2025 08:19AM
Barcode ID/Order ID : D19965811 / 13064439 Report Date : 05/Jun/2025 05:40PM
Sample Type : Serum Report Status : Final Report

BIOCHEMISTRY
SUPER EMPLOYEE HEALTH CHECK-UP
Test Name Result Unit Bio. Ref. Interval Method
*Please note test values may vary depending on the assay method used.

Kidney Function Test.

Blood Urea Nitrogen 11 mg/dL 7.0-16.8 Urease
Urea 23.54 mg/dL 14.9 - 35.9 Calculated
Creatinine 0.96 mg/dL 0.52-0.69 Kinetic Alkaline Picrate
Uric Acid 3.7 mg/dL 1.9-5.0 Uricase
Sodium 139 mmol/L 138-145 INDIRECT ISE
Potassium 3.70 mmol/L 3.4-4.7 INDIRECT ISE
Chloride 104.0 mmol/L 98-107 INDIRECT ISE
BUN/Creatinine Ratio 11.5 Ratio 12:1 - 20:1 Calculated
Urea/Creatinine Ratio 24.52 Ratio Calculated

Comment:
BUN is directly related to protein intake and nitrogen metabolism and inversely related to the rate of excretion of urea.Blood
urea nitrogen (BUN) levels reflect the balance between the production and excretion of urea. Increased levels are seen in renal
failure (acute or chronic), urinary tract obstruction, dehydration, shock, burns, CHF, GI bleeding, nephrotoxic drugs. Decreased
levels are seen in hepatic failure, nephrotic syndrome, cachexia (low-protein and high-carbohydrate diets).
Urea is a non-proteinous nitrogen compound formed in the liver from ammonia as an end product of protein metabolism. Urea
diffuses freely into extracellular and intracellular fluid and is ultimately excreted by the kidneys. Increased levels are found in
acute renal failure, chronic glomerulonephritis, congestive heart failure, decreased renal perfusion, diabetes, excessive protein
ingestion, gastrointestinal (GI) bleeding, hyperalimentation, hypovolemia, ketoacidosis, muscle wasting from starvation,
neoplasms, pyelonephritis, shock, urinary tract obstruction, nephrotoxic drugs. Decreased levels are seen in inadequate dietary
protein, low-protein/high-carbohydrate diet, malabsorption syndromes, pregnancy, severe liver disease, certain drugs.
Creatinine is catabolic product of creatinine phosphate, which is excreted by filtration through the glomerulus and by tubular
secretion. Creatinine clearance is an acceptable clinical measure of glomerular filtration rate (GFR). Increased levels are seen in
acute/chronic renal failure, urinary tract obstruction, hypothyroidism, nephrotoxic drugs, shock, dehydration, congestive heart
failure, diabetes. Decreased levels are found in muscular dystrophy.
BUN/Creatinine ratio(normally 12:1–20:1) is decreased in acute tubular necrosis, advanced liver disease, low protein intake,
and following hemodialysis. BUN/Creatinine ratio is increased in dehydration, GI bleeding, and increased catabolism.
Uric acid levels show diurnal variation. The level is usually higher in the morning and lower in the evening. Increased levels are
seen in starvation, strenuous exercise, malnutrition, or lead poisoning, gout, renal disorders, increased breakdown of body cells
in some cancers (including leukemia, lymphoma, and multiple myeloma) or cancer treatments, hemolytic anemia, sickle cell
anemia, or heart failure, pre-eclampsia, liver disease (cirrhosis), obesity, psoriasis, hypothyroidism, low blood levels of
parathyroid hormone (PTH), certain drugs, foods that are very high in purines - such as organ meats, red meats, some seafood
and beer. Decreased levels are seen in liver disease, Wilson's disease, Syndrome of inappropriate antidiuretic hormone (SIADH),
certain drugs.

This test has been performed at

TATA 1MG BANGALORE
Address: No 607, Ground, 1st & 2nd Floor, 80
Feet Road, 6th Block, Koramangala,
Bengaluru, 560095

Page 8 of 14
 PO No :PO3758436865-720

Name : Mr.MOHAMMED AZLAN Client Name : TATA 1MG BANGALORE

Age/Gender : 8/Male Referred By : Dr.
Patient ID : MGB1243922 Collection Date : 05/Jun/2025 08:19AM
Barcode ID/Order ID : D19965811 / 13064439 Report Date : 05/Jun/2025 07:02PM
Sample Type : Serum Report Status : Final Report

BIOCHEMISTRY
SUPER EMPLOYEE HEALTH CHECK-UP
Test Name Result Unit Bio. Ref. Interval Method

Iron Studies, Basic

Iron Serum 15 µg/dL 16 -128 Ferene
Unsaturated Iron Binding Capacity 251 µg/dL 69 - 240 Ferrin
Total Iron Binding Capacity ( TIBC) 266 µg/dL 250-460 Calculated
Transferrin Saturation 5.64 % 20 - 50 Calculated

Comment:

Iron is an essential trace mineral element which forms an important component of hemoglobin, metallocompounds and Vitamin
A. Deficiency of iron is seen in iron deficiency and anaemia of chronic disorders.
Increased iron concentration are seen in hemolytic anaemias, hemochromatosis and acute liver disease. Serum Iron alone is
unreliable due to considerable physiologic diurnal variation in the results with highest values in the morning and lowest values in
the evening as well as variation in response to iron therapy .

Total Iron Binding capacity (TIBC)is a direct measure of the protein Transferrin which transports iron from the gut to storage
sites in the bone marrow. Increased levels of TIBC suggest that total iron body stores are low, increased concentration may be
the sign of Iron deficiency anaemia, polycythemia vera ,and may occur during the third trimester of pregnancy. Decreased levels
may be seen in hemolytic anaemia, hemochromatosis, chronic liver disease, hypoproteinemia ,malnutrition.

Unsaturated Iron Binding Capacity (UIBC) is increased in low iron state and decreased in high iron concentration such as
hemochromatosis. In case of anaemia of chronic disease the patient may be anaemic but has adequate iron reserve and a low
uIBC.

Transferrin Saturationoccurs in Idiopathic hemochromatosis and Transfusional hemosiderosis where no unsaturated iron
binding capacity is available for iron mobilization. Similar condition is seen in congenital deficiency of Transferrin.

*Please note change in BRI.

*Please note test values may vary depending on the assay method used.

This test has been performed at

TATA 1MG BANGALORE
Address: No 607, Ground, 1st & 2nd Floor, 80
Feet Road, 6th Block, Koramangala,
Bengaluru, 560095

Page 9 of 14
This test has been performed at
TATA 1MG BANGALORE
Address: No 607, Ground, 1st & 2nd Floor, 80
Feet Road, 6th Block, Koramangala,
Bengaluru, 560095

Page 10 of 14
This test has been performed at
TATA 1MG BANGALORE
Address: No 607, Ground, 1st & 2nd Floor, 80
Feet Road, 6th Block, Koramangala,
Bengaluru, 560095

Page 11 of 14
 PO No :PO3758436865-720

Name : Mr.MOHAMMED AZLAN Client Name : TATA 1MG BANGALORE

Age/Gender : 8/Male Referred By : Dr.
Patient ID : MGB1243922 Collection Date : 05/Jun/2025 08:19AM
Barcode ID/Order ID : D19965811 / 13064439 Report Date : 05/Jun/2025 04:29PM
Sample Type : Serum Report Status : Final Report

IMMUNOLOGY
SUPER EMPLOYEE HEALTH CHECK-UP
Test Name Result Unit Bio. Ref. Interval Method
Vitamin D deficiency is a cause of secondary hyperparathyroidism and diseases resulting in impaired bone metabolism (like
rickets, osteomalacia).
Recently, many chronic diseases such as cancer, high blood pressure, osteoporosis and several autoimmune diseases
have been linked to vitamin D deficiency.
The assay measures both D2 (Ergocalciferol) and D3 (Cholecalciferol) metabolites of vitamin D

Utility Quantitative determination of 25-hydroxyvitamin D (25-OH vitamin D).

Vitamin B12
Vitamin B12 660.0 pg/mL 187-833 CMIA

Comment:

Vitamin B12 along with folate is essential for DNA synthesis and myelin formation.
Decreased levels are seen in anaemia, term pregnancy, vegetarian diet, intrinsic factor deficiency, partial
gastrectomy/ileal damage, celiac disease, oral contraceptive use, parasitic infestation, pancreatic deficiency, treated
epilepsy, smoking, hemodialysis and advanced age.
Increased levels are seen in renal failure, hepatocelluar disorders, myeloproliferative disorders and at times with excess
supplementation of vitamins pills.

This test has been performed at

TATA 1MG BANGALORE
Address: No 607, Ground, 1st & 2nd Floor, 80
Feet Road, 6th Block, Koramangala,
Bengaluru, 560095

Page 12 of 14
 PO No :PO3758436865-720

Name : Mr.MOHAMMED AZLAN Client Name : TATA 1MG BANGALORE

Age/Gender : 8/Male Referred By : Dr.
Patient ID : MGB1243922 Collection Date : 05/Jun/2025 08:19AM
Barcode ID/Order ID : D19965814 / 13064439 Report Date : 05/Jun/2025 04:07PM
Sample Type : Urine Report Status : Final Report

CLINICAL PATHOLOGY
SUPER EMPLOYEE HEALTH CHECK-UP
Test Name Result Unit Bio. Ref. Interval Method

Urine Routine & Microscopy

Urine Routine & Microscopy
Colour YELLOW Pale Yellow
Appearance Turbid Clear Visual
Specific gravity 1.010 1.003 - 1.035 pKa change
pH 7.0 4.6 - 8.0 Double Indicator
Glucose Negative Negative GOD-POD
Protein 1+ Negative Protein Error Principle
Ketones Negative Negative Nitroprusside
Blood 1+ Negative Peroxidase
Bilirubin Negative Negative Diazonium
Urobilinogen Normal Normal Ehrlich
Leucocyte Esterase 3+ Negative Pyrrole
Nitrite Negative Negative Diazonium Compound
Pus cells Abundant /hpf 0-5 Microscopy
Red Blood Cells 3-4 /hpf 0-2 Microscopy
Epithelial cells 1-2 /hpf Few Microscopy
Casts Pus Cast /lpf Nil Microscopy
Crystals Nil Nil Microscopy
Yeast Nil Nil Microscopy
Bacteria Plenty Nil Microscopy
Urine protein confirmed by manual confirmatory method.

Comment:
•Note: Pre-test condition to be observed while submitting the sample-first void, mid stream urine, collected in a clean, dry, sterile
container is recommended for routine urine analysis, avoid contamination with any discharge from vaginal, urethra, perineum,
Avoid prolonged transit time & undue exposure to sunlight.
•During interpretation, points to be considered are Negative nitrite test does not exclude the urinary tract infections. Trace
proteinuria can be seen with many physiological conditions like prolonged recumbency, exercise, high protein diet. False positive
reactions for bile pigments, proteins, glucose and nitrites can be caused by peroxidase like activity by disinfectants, therapeutic
dyes, ascorbic acid and certain drugs. • Urine microscopy is done in centrifuged urine specimens

This test has been performed at

TATA 1MG BANGALORE
Address: No 607, Ground, 1st & 2nd Floor, 80
Feet Road, 6th Block, Koramangala,
Bengaluru, 560095

Page 13 of 14
 PO No :PO3758436865-720

Name : Mr.MOHAMMED AZLAN Client Name : TATA 1MG BANGALORE

Age/Gender : 8/Male Referred By : Dr.
Patient ID : MGB1243922 Collection Date : 05/Jun/2025 08:19AM
Barcode ID/Order ID : D19965814 / 13064439 Report Date : 05/Jun/2025 04:07PM
Sample Type : Urine Report Status : Final Report

CLINICAL PATHOLOGY
SUPER EMPLOYEE HEALTH CHECK-UP
Test Name Result Unit Bio. Ref. Interval Method

*** End Of Report ***

Conditions of Laboratory Testing & Reporting:
Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should
be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report
may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal
purposes. Please mail your queries related to test results to Customer Care mall ID care@1mg.com

Disclaimer : Results relate only to the sample received. Test results marked "BOLD" indicate abnormal results i.e. higher or lower than normal. All
lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes.
Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the
information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be
vetted by a qualified doctor only.

This test has been performed at

TATA 1MG BANGALORE
Address: No 607, Ground, 1st & 2nd Floor, 80
Feet Road, 6th Block, Koramangala,
Bengaluru, 560095

Page 14 of 14
 Ensuring accuracy IN every single report
Following a 3-step review process:

Advanced systems & Experienced lab experts Each report undergoes

cutting-edge technology analyze and technicians conduct rigorous medical scrutiny & is
results with precision comprehensive reviews signed off by a doctor

Have concerns regarding the report?

Reach out to our care team at care@1mg.com or
chat with us
CONNECT NOW >

Accurate Testing, Assured Quality: Diagnostics Precision

Stringent quality Cutting-edge Experienced lab staff

control technology 30+ medical
Measures meeting Robust healthcare systems professionals with a
international norms of equipped with calibrated & collective experience of
safety guidelines well-maintained machinery 200+ years

Verified test
External assessments Trained phlebotomists
procedures
Thorough third-party Ensuring smooth sample
Highly standardized test
assessment by authorized collection experience &
procedures following CLSI*
experts pre-analytical precision
guidelines
*Clinical & Laboratory Standards Institute T&C Apply